- Stock: IN STOCK
- Brand: DEUS MEDICAL
- Reward Points: RECEIVE 6 REWARD POINTS
- Model: PT-141
- Review count: 1 , Add testimonial
- Average rating: 5
PT-141 (Bremelanotide) — research peptide
PT-141 (bremelanotide) is a melanocortin-receptor peptide studied for pathways related to libido and arousal — a mechanism quite distinct from the blood-flow action of the PDE5 inhibitors, which is why it occupies its own niche in research. That central, receptor-mediated profile is its defining feature. HelixaMed supplies PT-141 lyophilised and lab-verified for identity and concentration.
As with every peptide, correct handling is essential: freeze-dried on arrival, reconstituted with bacteriostatic water and stored cold. Our guides cover the process so a study runs on stable material. This is a research-use compound only; no dosing or human-use instructions are provided.
- Distinct mechanism: melanocortin-receptor, not blood-flow.
- Cold-chain sensitive: reconstitute and refrigerate.
- Verified: lyophilised, batch-analysed.
WHAT IS PT-141:
Bremelanotide (PT-141) was developed from the peptide hormone MELANOTAN II.
Most of the research has been targeted to women with female sexual dysfunction an it is effective medication in treating sexual dysfunction in both men (erectile dysfunction or impotence), it does not act upon the vascular system, but directly increases sexual desire via the nervous system.
Bremelanotide currently has no contraindications and is 80% effective in men don’t respond to Viagra or Cialis. For women, it causes a 50% increase in sexually satisfying experiences.
ALSO KNOWN AS:
Rekynda
Bremelanotide acetate
PT 141 DOSAGE:
Bremelanotide 10mg/vial
PACKAGE CONTENT:
1 Box of 1 Vial
HOW TO USE PT 141 PEPTIDE:
Inject 2mg subcutaneously as needed, 30 minutes to 6 hours prior to sexual activity. The initial dose will establish a time frame for response. Men should start at 1mg and titrate up to and not exceed 2mg. Women should start at 2mg dosing protocol.